Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for PRPO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -0.132M
March 31, 2026 -0.05M
December 31, 2025 -0.075M
September 30, 2025 -0.054M
June 30, 2025 -0.059M
March 31, 2025 -0.138M
December 31, 2024 -0.044M
September 30, 2024 -0.109M
June 30, 2024 -0.07M
March 31, 2024 0.00
December 31, 2023 -0.049M
September 30, 2023 -0.023M
June 30, 2023 -0.032M
March 31, 2023 -0.022M
December 31, 2022 -0.052M
September 30, 2022 -0.119M
June 30, 2022 -0.096M
March 31, 2022 -0.01M
December 31, 2021 -0.058M
September 30, 2021 -0.303M
June 30, 2021 -0.136M
March 31, 2021 -0.185M
December 31, 2020 -0.03M
September 30, 2020 -0.056M
June 30, 2020 0.014M
Date Value
March 31, 2020 -0.024M
December 31, 2019 -0.006M
September 30, 2019 -0.019M
June 30, 2019 -0.027M
March 31, 2019 -0.003M
December 31, 2018 -0.031M
September 30, 2018 -0.022M
June 30, 2018 -0.039M
March 31, 2018 -0.005M
December 31, 2017 -0.143M
September 30, 2017 0.00
June 30, 2017 0.101M
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.026M
March 31, 2016 -0.026M
December 31, 2015 0.166M
September 30, 2015 1.861M
June 30, 2015 -0.24M
March 31, 2015 0.00
December 31, 2014 0.152M
September 30, 2014 3.645M
June 30, 2014 -0.079M
March 31, 2014 -0.093M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
NeoGenomics, Inc. -8.319M
Quest Diagnostics, Inc. -134.00M
Labcorp Holdings, Inc. -366.20M
OPKO Health, Inc. 15.54M
Psychemedics Corp. --